Showing results (41-50 of 172) with videos related to
Sort By:
Pageof 18
Plos One|March 31, 2011
Hsp12.6 expression is inducible by host immunity in adult worms of the parasitic nematode Nippostrongylus brasiliensisNaoki Arizono, Minoru Yamada, Tatsuya Tegoshi, et al.Cancer Chemotherapy and Pharmacology|July 16, 2016
Effects of a bolus injection of 5-fluorouracil on dihydropyrimidine dehydrogenase activity in rats receiving continuous infusion of 5-fluorouracilShinji Kobuchi, Asuka Hayashi, Mayu Taniguchi, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|March 12, 2004
Prolonged circulation of menatetrenone by emulsions with hydrogenated castor oils in ratsKumiko Ueda, Takashi Furukawa, Yuriko Kawaguchi, et al.Journal of Drug Targeting|October 28, 2003
Effect of particle size on the pharmacokinetics of menatetrenone incorporated in O/W lipid emulsions prepared with hydrogenated castor oils and soybean oil in ratsKumiko Ueda, Yuka Yamazaki, Yasuko Teshima, et al.Journal of Clinical Pharmacology|April 29, 2009
Effects of statins on the pharmacokinetics of midazolam in healthy volunteersMakiko Kokudai, Naoki Inui, Kazuhiko Takeuchi, et al.Biological & Pharmaceutical Bulletin|December 25, 2002
MDR1-mediated interaction of digoxin with antiarrhythmic or antianginal drugsMikio Kakumoto, Kohji Takara, Toshiyuki Sakaeda, et al.The Journal of Pharmacy and Pharmacology|October 25, 2002
Effect of oxyethylene moiety in polyoxyethylene sorbitan esters on the pharmacokinetics of menatetrenone incorporated in O/W lipid emulsions prepared with polyoxyethylene sorbitan esters and soybean oil in ratsKumiko Ueda, Masanori Fujimoto, Hiromi Noto, et al.International Journal of Medical Sciences|June 20, 2013
A survey of the FAERS database concerning the adverse event profiles of α1-adrenoreceptor blockers for lower urinary tract symptomsKoji Yoshimura, Kaori Kadoyama, Toshiyuki Sakaeda, et al.Xenobiotica; the Fate of Foreign Compounds in Biological Systems|August 20, 2019
Pharmacokinetics and lung distribution of macrolide antibiotics in sepsis model ratsShinji Kobuchi, Akihiro Fujita, Akihito Kato, et al.Cancer Chemotherapy and Pharmacology|August 7, 2025
Model-informed drug repurposing of proton pump inhibitors for the prevention of oxaliplatin induced peripheral neuropathy: A real-world data analysis and pharmacometrics approachYasuhito Tsukushi, Kanade Koriyama, Shinji Kobuchi, et al.Pageof 18